Advanced search
1 file | 912.18 KB

Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction

Sarah Buelens (UGent) , Tom Claeys, Bert Dhondt (UGent) , Filip Poelaert (UGent) , Matthijs Vynck (UGent) , Nurten Yigit (UGent) , Olivier Thas (UGent) , Piet Ost (UGent) , Jo Vandesompele (UGent) , Nicolaas Lumen (UGent) , et al.
(2018) CLINICAL GENITOURINARY CANCER. 16(3). p.197-205
Author
Organization
Keywords
Abiraterone, Circulating cell-free DNA, CRPC, Enzalutamide, Resistance, INCREASED SURVIVAL, CASTRATION, RESISTANCE, ENZALUTAMIDE, AXIS, AMPLIFICATIONS, CHEMOTHERAPY, THERAPIES, DNA

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 912.18 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Buelens, Sarah, Tom Claeys, Bert Dhondt, Filip Poelaert, Matthijs Vynck, Nurten Yigit, Olivier Thas, et al. 2018. “Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction.” Clinical Genitourinary Cancer 16 (3): 197–205.
APA
Buelens, S., Claeys, T., Dhondt, B., Poelaert, F., Vynck, M., Yigit, N., Thas, O., et al. (2018). Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction. CLINICAL GENITOURINARY CANCER, 16(3), 197–205.
Vancouver
1.
Buelens S, Claeys T, Dhondt B, Poelaert F, Vynck M, Yigit N, et al. Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction. CLINICAL GENITOURINARY CANCER. 2018;16(3):197–205.
MLA
Buelens, Sarah, Tom Claeys, Bert Dhondt, et al. “Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction.” CLINICAL GENITOURINARY CANCER 16.3 (2018): 197–205. Print.
@article{8543299,
  author       = {Buelens, Sarah and Claeys, Tom and Dhondt, Bert and Poelaert, Filip and Vynck, Matthijs and Yigit, Nurten and Thas, Olivier and Ost, Piet and Vandesompele, Jo and Lumen, Nicolaas and Kumps, Candy},
  issn         = {1558-7673},
  journal      = {CLINICAL GENITOURINARY CANCER},
  keywords     = {Abiraterone,Circulating cell-free DNA,CRPC,Enzalutamide,Resistance,INCREASED SURVIVAL,CASTRATION,RESISTANCE,ENZALUTAMIDE,AXIS,AMPLIFICATIONS,CHEMOTHERAPY,THERAPIES,DNA},
  language     = {eng},
  number       = {3},
  pages        = {197--205},
  title        = {Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction},
  url          = {http://dx.doi.org/10.1016/j.clgc.2017.12.008},
  volume       = {16},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: